Biological and clinical response to omalizumab in a patient with bullous pemphigoid

Sébastien Menzinger; Gürkan Kaya; Enno Schmidt; Lionel Fontao; Emmanuel Laffitte

doi:10.2340/00015555-2845

Biological and clinical response to omalizumab in a patient with bullous pemphigoid

Sébastien Menzinger, Gürkan Kaya, Enno Schmidt, Lionel Fontao, Emmanuel Laffitte

Department of Dermatology, Allergology and Venereology

University Hospital and Medical Faculty

20 Citations (Scopus)

Original language	English
Journal	Acta Dermato-Venereologica
Volume	98
Issue number	2
Pages (from-to)	284-286
Number of pages	3
ISSN	0001-5555
DOIs	https://doi.org/10.2340/00015555-2845
Publication status	Published - 02.2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Access to Document

10.2340/00015555-2845

Cite this

@article{9678c6adc76548a58d7fb672792b3c2f,

title = "Biological and clinical response to omalizumab in a patient with bullous pemphigoid",

author = "S{\'e}bastien Menzinger and G{\"u}rkan Kaya and Enno Schmidt and Lionel Fontao and Emmanuel Laffitte",

year = "2018",

month = feb,

doi = "10.2340/00015555-2845",

language = "English",

volume = "98",

pages = "284--286",

journal = "Acta Dermato-Venereologica",

issn = "0001-5555",

publisher = "Medical Journals Sweden AB",

number = "2",

}

TY - JOUR

T1 - Biological and clinical response to omalizumab in a patient with bullous pemphigoid

AU - Menzinger, Sébastien

AU - Kaya, Gürkan

AU - Schmidt, Enno

AU - Fontao, Lionel

AU - Laffitte, Emmanuel

PY - 2018/2

Y1 - 2018/2

UR - https://www.scopus.com/pages/publications/85041333993

U2 - 10.2340/00015555-2845

DO - 10.2340/00015555-2845

M3 - Comments/Debates

C2 - 29136264

AN - SCOPUS:85041333993

SN - 0001-5555

VL - 98

SP - 284

EP - 286

JO - Acta Dermato-Venereologica

JF - Acta Dermato-Venereologica

IS - 2

ER -

Biological and clinical response to omalizumab in a patient with bullous pemphigoid

UN SDGs

Research Areas and Centers

Access to Document

Other files and links

Cite this